Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Functionalized Magnetic Nanoparticles for Cancer Therapy Publisher



Sabzini M1 ; Moradi A2 ; Sahrayi H2 ; Shamsabadipour A1 ; Namazifard S3 ; Hojjati S4 ; Mostafavi E5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biotechnology Engineering, School of Chemical Engineering, University of Tehran, Tehran, Iran
  2. 2. Department of Chemical and Petrochemical Engineering, Sharif University of Technology, Tehran, Iran
  3. 3. Department of Mechanical and Aerospace Engineering, The University of Texas at Arlington, Arlington, TX, United States
  4. 4. Department of Pharmaceutical Biotechnology, School of Pharmacy, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran
  5. 5. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, United States
  6. 6. Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States

Source: Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices Published:2024


Abstract

Magnetic nanoparticles (MNPs) belong to a class of applicable materials for cancer therapy purposes because of their multifaceted nature. Their magnetic guidance characteristics, biocompatibility, stability, and general-purpose design have made MNPs a multimodal delivery platform for targeted cancer treatment. MNPs have been actively considered as the next generation of nanocarriers for transporting anticancer drugs into the tumor environment under several environmental factors with limited side effects on the human body. Besides, MNPs also have been utilized in combination cancer therapies, such as chemo-magnetic hyperthermia, and chemo photothermal therapy, among others, owing to their multifunctional properties. To better use MNPs for cancer therapy, surface functionalization is necessary, as is reducing the cytotoxicity of healthy tissue, increasing circulation time, specific targeting of tumor cells, and managing the sustained release of anticancer agents. Using functionalized magnetic nanoparticles (fMNPs) for cancer therapy purposes need to cover particular criteria for size distribution, surface charge, and biodegradability for specific tumor site. To work in optimal conditions, the utilization of fMNPs depends basically on the preparation processes, which will be highlighted throughout this chapter. First of all, in this chapter, we have provided an overview of MNPs and their merits and demerits. Also, we discussed the application of MNPs in targeted drug delivery systems (DDS) and mentioned the history of MNPs production. Moreover, the drug delivery mechanism of fMNPs and previous in vitro and in vivo studies of targeted DDS, which utilized fMNPs as nano vehicles, are explained. Finally, prospects for the use of fMNPs in cancer therapy and current status and prediction have been highlighted. © 2024 Elsevier Inc. All rights reserved.
Other Related Docs
14. Nanomaterials and Nanotechnology for Water Treatment: Recent Advances, Inorganic and Nano-Metal Chemistry (2021)
20. Synthesis and Cytotoxicity Assessment of Gold-Coated Magnetic Iron Oxide Nanoparticles, Journal of Biomedical Physics and Engineering (2018)
27. Fabrication of Pla/Mwcnt/Fe 3O 4 Composite Nanofibers for Leukemia Cancer Cells, International Journal of Polymeric Materials and Polymeric Biomaterials (2016)
30. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
31. Plga-Peg-Ra-Based Polymeric Micelles for Tumor Targeted Delivery of Irinotecan, Pharmaceutical Development and Technology (2018)
32. Mxenes in Photomedicine: Advances and Prospects, Chemical Communications (2022)
33. Recent Progress in Cancer Immunotherapy: Application of Nano-Therapeutic Systems, Journal of Drug Delivery Science and Technology (2024)
39. Mxenes for Cancer Therapy and Diagnosis: Recent Advances and Current Challenges, ACS Biomaterials Science and Engineering (2021)
43. Advanced Nanosystems for Cancer Therapeutics: A Review, ACS Applied Nano Materials (2023)